Need professional-grade analysis? Visit stockanalysis.com
$407.85M
N/A
29
N/A
Spectral Med Inc (EDT) trades on Toronto Stock Exchange in CAD. The company is classified in the Healthcare sector under the Diagnostics & Research industry. The stock currently trades at CAD1.36, down 2.16% from the previous close.
Over the past year, EDT has traded between a low of CAD0.78 and a high of CAD1.75. The stock has gained 70.0% over this period. It is currently 22.3% below its 52-week high.
Spectral Med Inc has a market capitalization of $407.85M.
Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally. The company markets Endotoxin Activity Assay, a rapid in-vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B-Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops, manufactures, and markets monoclonal and polyclonal antibodies, recombinant cardiac proteins, antibodies, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada.
Side-by-side comparison against top Healthcare peers.